Similar articles

• Reduction in the expression of glucose transporter protein GLUT 2 in preneoplastic and neoplastic hepatic lesions and reexpression of GLUT 1 in late stages of hepatocarcinogenesis.

  Grobholz R, Hacker HJ, Thorens B, Bannasch P. Grobholz R, et al. Cancer Res. 1993 Sep 15;53(18):4204-11. Cancer Res. 1993. PMID: 8364915
• Toxicogenomic analysis of N-nitrosomorpholine induced changes in rat liver: comparison of genomic and proteomic responses and anchoring to histopathological parameters.

  Oberemm A, Ahr HJ, Bannasch P, Ellinger-Ziegelbauer H, Glückmann M, Hellmann J, Ittrich C, Kopp-Schneider A, Kramer PJ, Krause E, Kröger M, Kiss E, Richter-Reichhelm HB, Scholz G, Seemann K, Weimer M, Gundert-Remy U. Oberemm A, et al. Toxicol Appl Pharmacol. 2009 Dec 1;241(2):230-45. doi: 10.1016/j.taap.2009.08.020. Epub 2009 Aug 28. Toxicol Appl Pharmacol. 2009. PMID: 19716841
• Rat hepatocarcinogenesis induced by N-nitrosodiethylamine and N-nitrosomorpholine continuously administered at low doses. From basophilic areas of hepatocytes to hepatocellular tumors.

  Cortinovis C, Klimek F, Nogueira E. Cortinovis C, et al. Am J Pathol. 1991 Nov;139(5):1157-71. Am J Pathol. 1991. PMID: 1951631 Free PMC article.
• Inhibition by neostigmine of hepatocarcinogenesis induced by N-nitrosomorpholine in Sprague-Dawley rats.

  Tatsuta M, Iishi H, Baba M, Uehara H, Nakaizumi A. Tatsuta M, et al. Br J Cancer. 1990 Nov;62(5):773-5. doi: 10.1038/bjc.1990.377. Br J Cancer. 1990. PMID: 1978785 Free PMC article. No abstract available.
• [Effect of ascorbic acid on the hepatocarcinogenic action of N-nitrosodiethylamine in rats].

  Birk RV, Kil'dema LA, Teras LE. Birk RV, et al. Eksp Onkol. 1988;10(6):66-8. Eksp Onkol. 1988. PMID: 2854047 Russian.